Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Carcinoma, Renal Cell 5 Neoplasms 4 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Leukemia, Myeloid, Chronic-Phase 3 Ovarian Neoplasms 2 Neoplasm, Residual 2 NSCLC 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Recurrence 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Philadelphia Chromosome 1 Neoplasms, Second Primary 1 Neoplasms by Site 1 Lung Diseases 1 Liver Neoplasms 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1

Interventions

masitinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gastro Intestinal Stromal Tumor × Tyrosine Kinase Inhibitors × Clear all

NCT03963544 2025-12-10

METAGIST

Institut Bergonié

492 enrolled 7 charts

Gastro Intestinal Stromal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡